Terumo Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRUMF research report →
About the company
Terumo Corporation is a global medical technology company specializing in the development, manufacturing, and distribution of a wide array of healthcare products and equipment. Its comprehensive operations are structured across three key segments: Cardiac and Vascular, Medical Care Solutions, and Blood and Cell Technologies. The Cardiac and Vascular segment provides an extensive portfolio for cardiovascular and interventional procedures.
- CEO
- Hikaru Samejima
- IPO
- 2011
- Employees
- 30,207
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $19.28B
- P/E
- 24.51
- P/S
- 2.94
- P/B
- 2.10
- EV/EBITDA
- 12.37
- Div Yield
- 1.33%
- Gross Margin
- 52.54%
- Op Margin
- 16.32%
- Net Margin
- 12.01%
- ROE
- 9.19%
- ROIC
- 6.87%
- Revenue
- $1.14T · 9.92%
- Net Income
- $136.77B · 16.92%
- EPS
- $92.67 · 17.29%
- Op Income
- $185.90B
- FCF YoY
- 14.11%
- 52W High
- $20.46
- 52W Low
- $11.49
- 50D MA
- $13.32
- 200D MA
- $14.16
- Beta
- 0.23
- Avg Volume
- 3.25K
Get TickerSpark's AI analysis on TRUMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TRUMF coverage
Recent articles, reports, and earnings notes.
No research on TRUMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRUMF report →Similar companies
Peers in the same neighborhood.